Article
Association between methylenetetrahydrofolate reductase polymorphisms and the relapse of acute lymphoblastic leukemia: a meta-analysis.
The pharmacogenomics journal - 1 Oct 2014
He H-R, Chen S-Y, You H-S, Hu S-S, Sun J-Y, Dong Y-L, Lu J
Abstract excerpt
Relapse is a threat in patients treated for acute lymphoblastic leukemia (ALL). Methylenetetrahydrofolate reductase (MTHFR) activity may affect the sensitivity of patients to folate-based chemotherapeutic drugs, thus influencing the relapse risk. Two polymorphisms of the gene encoding MTHFR, C677T and A1298C, alter MTHFR enzyme activity and may be associated with ALL relapse. The aim of this meta-analysis was to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
